What 'leaky gut' actually means

The gut barrier is a complex structure consisting of mucus layers, the intestinal epithelial cell monolayer connected by tight junctions, and the underlying immune and structural components. The tight junctions are regulated structures that permit controlled passage of specific molecules while blocking others. 'Leaky gut' is the popular term for what's more accurately called increased intestinal permeability — a state in which the tight junctions are more permissive than normal.

This is real biology. Intestinal permeability is regulated by signaling molecules including zonulin, and pathological increases in permeability are documented in multiple recognized conditions — celiac disease, inflammatory bowel disease, NSAID injury, and critical illness. The clinical and research literature establishes that the biology is genuine.

Where the controversy lives

The dispute between mainstream gastroenterology and the functional medicine ecosystem isn't about whether intestinal permeability is real biology — both sides acknowledge it where it's clearly established. The dispute is about its clinical significance outside those contexts, and about the interventions marketed as treating it. The functional medicine position has often positioned leaky gut as a primary driver of a wide range of conditions; the mainstream position has been that outside recognized conditions, increased permeability hasn't been definitively established as a clinically significant driver of systemic disease. Both positions have merit.

Where increased permeability clinically matters

In recognized conditions where increased permeability is well-established, addressing the underlying condition addresses the permeability. In post-infectious states, increased permeability often persists for months and contributes to ongoing symptoms. In patients with significant dysbiosis, food sensitivities, and chronic inflammation, gut barrier function is often part of the picture. In autoimmune disease, the connection between gut barrier function and immune dysregulation is increasingly characterized in research.

How iHeal approaches this clinically

The approach is to address gut health comprehensively rather than to treat 'leaky gut' as a discrete condition. Most patients who arrive asking about leaky gut have broader gut dysfunction — dysbiosis, food sensitivities, GI symptoms, sometimes SIBO or SIFO — that warrants evaluation. Evaluation considers the broader clinical picture rather than permeability testing alone. Treatment focuses on the addressable contributors: dietary patterns, microbiome work, reducing the burden, supporting digestive function, and time.

Sources & Further Reading

• Cleveland Clinic: Leaky Gut Syndrome my.clevelandclinic.org/health/diseases/leaky-gut-syndrome ↗
• Peer-Reviewed: Intestinal permeability in clinical practice — PubMed-indexed; Gut, Gastroenterology, Tissue Barriers
• Peer-Reviewed: Zonulin and tight junction regulation — PubMed-indexed; Physiological Reviews, Nutrients
• Peer-Reviewed: Gut barrier function and autoimmune disease — PubMed-indexed; Frontiers in Immunology, Autoimmunity Reviews